Enanta Pharmaceuticals
ENTA · NASDAQ
$11.67+$0.26 (+2.28%)TodayMarket closed ·
Prev close $11.41
Who owns ENTA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 63.2% of ENTA’s shares.
- Janus Henderson Investors12.6%
- Krensavage Asset Management, LLC9.9%
- Farallon Capital Management, L.L.C.8.3%
- BlackRock Institutional Trust Company, N.A.7.7%
- Next 6 largest institutions24.7%
- All other shareholders36.8%
| Holder | Shares | % of shares |
|---|---|---|
| Janus Henderson Investors | 3.65M | 12.57% |
| Krensavage Asset Management, LLC | 2.87M | 9.86% |
| Farallon Capital Management, L.L.C. | 2.42M | 8.32% |
| BlackRock Institutional Trust Company, N.A. | 2.25M | 7.73% |
| Deep Track Capital LP | 1.44M | 4.97% |
| Adar1 Capital Management LLC | 1.34M | 4.62% |
| Vanguard Capital Management, LLC | 1.21M | 4.17% |
| Spruce Street Capital LP | 1.09M | 3.74% |
| Acadian Asset Management LLC | 1.08M | 3.71% |
| Vanguard Portfolio Management, LLC | 1.01M | 3.48% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 877.12K | 3.02% |
| iShares Russell 2000 ETF | 732.70K | 2.52% |
| BlackRock Health Sciences Opportunities Portfolio | 492.00K | 1.69% |
| Vanguard Extended Market Index Fund | 308.99K | 1.06% |
| Fidelity Small Cap Index Fund | 306.01K | 1.05% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of ENTA in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Rottinghaus Scott T. | Tax withholding | 1.47K | $19.57K |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.55M
- Days to cover
- 9.19
- % of shares outstanding
- 8.78%
- Average daily volume
- 277.69K
- Change since last report
- −1.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.